N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸

N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸性质、用途与生产工艺

概述

N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸 上下游产品信息

上游原料

下游产品

N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸 生产厂家

401915-53-5, N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸 相关搜索:

• amino acids
• 化学品
• 抑制剂
• 保护氨基酸-Homo氨基酸
• 生化试剂
• 有机原料
• 保护氨基酸
• 肽类氨基酸系列
• 保护氨基酸系列
• 非天然氨基酸
• 合成
• 非天然氨基酸极其衍生物
• 1159380-21-3
• FMOC-PBF-L-高精氨酸
• FMOC-HOMOARG(PBF)-OH;≥98%
• N-芴甲氧羰酰基-2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰-L-高精氨酸
• FMOC-高精氨酸(PBF)-OH
• (S)-3-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-(3-((2,2,4,6,7-五甲基-2,3-二氢苯并呋喃-5-基)磺酰基)胍基)己酸
• (3S)-6-[[[[(2,3-二氢-2,2,4,6,7-五甲基-5-苯并呋喃基)磺酰]氨基]亚氨甲基]氨基]-3-[[(9H-芴-9-基甲氧基)羰基]氨基]己酸
• N-FMOC-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸
• FMOC-Β-高精氨酸(PBF)
• NALPHA-FMOC-NOMEGA-(2,2,4,6,7-五甲基-2,3-二氢苯并[B]呋喃-5磺酸基)-L-B-高精氨酸
• FMOC-高精氨酸-PBF
• (S)-3-(FMOC-氨基)-6-[3-(2,2,4,6,7-五甲基-2,3-二氢苯并呋喃-5-基磺酰基)胍基]己酸
• NALPHA-FMOC-NOMEGA-(2,2,4,6,7-五甲基-2,3-二氢苯并[B]呋喃-5磺酸基)-L-Β-高精氨酸, >97%
• NALPHA-FMOC-NOMEGA-(2,2,4,6,7-五甲基-2,3-二氢苯并[B]呋喃-5磺酸基)-L-Β-高精氨酸
• N-芴甲氧羰基-N'-(2,2,4,6,7-五甲基二氢苯并呋喃-5-磺酰基)-L-高精氨酸
• 401915-53-5
• Fmoc-beta-HArg(Pbf)-OH
• Fmoc-Pbf-L-High arginine
• Fmoc-β-HomArg(pbf)-OH
• Fmoc-Har(pbf)-OH
• N-fluoromethoxycarbonyl-N '- (2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl) - L-homoarginine
• Nalpha-Fmoc-N^w-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine, 95%,
• Hexanoic acid,6-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-ben...
• FMOC-BETA-HOARG(PBF)-OH
• Fmoc-β-HoArg(Pbf)-OH
• N-β-(9-Fluorenylmethoxycarbonyl)-N-ω-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-β-homoarginine
• Fmoc-N-Pbf-L-HomoArginine USP/EP/BP
• Fmoc-L-β-Homo-Arg(Pbf)-OH
• Fmoc-β-HomoArg(Pbf)-OH
• Fmoc-L-b-HomoArg(Pbf)-OH
• (2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-6-[1-(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-sulfonyl)carbamimidamido]hexanoic acid
• N-Fmoc-N'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-homoarginine
• Fmoc-2-HoArg(Pbf)-OH
• Nalpha-Fmoc-Nomega-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-beta-homoarginine
• Hexanoic acid,6-[[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]amino]-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-,(3S)-
• Fmoc-HomArg(pbf)-OH
• (3S)-3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{N'-[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}hexanoic acid
• Fmoc-L-HomoArg(Pbf)-OH, >97%
• (S)-3-(Fmoc-amino)-6-[3-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)guanidino]hexanoic Acid
• -[(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-yl)sulfonyl]carbamimidamido}hexanoic acid
• FMOC-HOMO-ARG
• FMoc-D-beta-hoMoarginine(Pbf)
• N-Fmoc-N'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sufonyl)-L-homearginine
• Fmoc-N-Pbf-L-HomoArginine
• N^a-FMoc-N^w-(2,2,4,6,7-pentaMethyl-2,3-dihydrobenzo[b]furan-5-ylsulfonyl)-L-^b-hoMoarginine, 95%
• N-alpha-FMoc-N-oMega-(2,2,4,6,7-pentaMethyldihydrobenzofuran-5-sulfonyl)-L-hoMoarginine